MedPath

Prospective evaluation of disease free survival and Quality of Life following microvascular reconstruction in early oral squamous cell carcinoma

Recruiting
Conditions
C06.9
Mouth, unspecified
Registration Number
DRKS00013041
Lead Sponsor
Klinik und Poliklinik für Mund-, Kiefer- und GesichtschirurgieKopfklinikUniversitätsklinikum Heidelberg
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Squamous cell carcinoma of the oral cavity with T-Stage T1 or T2 and clinically negative neck node Status (cN0)

Surgical Treatment via Tumor resection, Neck Dissection and microvacular reconstruction

Minimum Age: 18 years

Exclusion Criteria

Recurrence of Prior oral squamous cell carinoma
Lack of understanding or legal Age for written consent

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Disease free survival (DFS) for 24 months following Primary therapy evaluated by regular clinical and MRI examinations
Secondary Outcome Measures
NameTimeMethod
Postoperative Quality of Life (QLQ-C30 and QLQ-H&N35) 3, 6, 12, 18 and 24 months after Primary therapy in comparison to baseline.<br>Tumorrelated cause of death<br>
© Copyright 2025. All Rights Reserved by MedPath